Determining cytotoxicity (being toxic to cells) is a critical component of identifying compound viability early in the preclinical phase of drug development or new product discovery. Cytotoxicity Screens (measuring cell death or cell viability) are used to give researchers key insight into potential adverse effects due to cell death prior to entering more costly in vivo studies.
IONTOX's cytotoxicity screens range from predictive multi-endpoint models to standard cell viability screens (ATP) to rank order compounds or mitochondrial toxicity assessments for companies wishing to understand how their compound effects mitochondrial health.
Review the pages below to select a cytotoxicity assay that best fits your organizations's needs. Multiple assays are frequently used when assessing cytotoxicity.